Xinhua Asia-Pacific news summary at 1600 GMT, Oct. 2


JAKARTA — The total number of COVID-19 cases in the Southeast Asian countries has reached over 700,000 on Friday, official sources said.

The Philippines has the highest number of COVID-19 cases among the Association of Southeast Asian Nations (ASEAN) members, with a total of 316,678. (Indonesia-ASEAN-COVID-19)

– – – –

NEW DELHI — Hundreds of people Friday evening gathered at Jantar Mantar in the heart of Indian capital city New Delhi to protest against the gangrape and murder of a young Dalit woman in the northern state of Uttar Pradesh.

The protesters including civil society activists, women, students and members of various political parties gathered to demand justice for the victim family. (India-Protest-Rape)

– – – –

TOKYO — Tokyo Gov. Yuriko Koike said Friday that the Japanese capital is mulling extending the loan period of giant panda Xiang Xiang’s parents, male panda Ri Ri and female Shin Shin.

Ri Ri and Shin Shin, both 15, came to Japan from China in February 2011 under a 10-year lease agreement. (Japan-Panda-Lease)

– – – –

CANBERRA — Australian doctors have warned against rapid coronavirus tests, saying they are unreliable.

The country’s Therapeutic Goods Administration (TGA) in late September approved COVID-19 tests that can produce results in 15 minutes compared to a day or more for conventional tests. (Australia-COVID-19-Test)

– – – –

NEW DELHI — The Indian Medical Association (IMA), an association of doctors in India, said Friday over 500 doctors have died in the line of duty during the ongoing COVID-19 pandemic across the country.

READ  Fr Polash Henry Gomes, from Bangladesh to the Philippines to bear witness to Christ

“The IMA dedicates the sacrifice of 515 Indian doctors in the fight against COVID-19 pandemic to the nation. We salute these martyrs. We salute all the nurses and the healthcare workers who sacrificed their lives as well,” IMA wrote on social media. (India-COVID-19-Doctor-Death) Enditem



READ SOURCE

LEAVE A REPLY

Please enter your comment!
Please enter your name here